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Sickle Cell Disease in Georgia
What is RuSH?
•• Registry and Surveillance System for Hemoglobinopathies
(RuSH) was a pilot project of the Centers for Disease
Control and Prevention (CDC), with the National Institutes
of Health’s National Heart, Lung, and Blood Institute.
•• The overall purpose of RuSH was to collect state-specific,
population-based data on people with sickle cell disease
(SCD) and thalassemia in order to provide accurate
updated information to the public.

Findings from RuSH
Facts for Providers

The Sickle Cell Population in Georgia
SCD occurs in individuals of all geographic and ethnic
backgrounds. We estimate that 97% or more of Georgia
newborns with SCD are Black or African-American, and roughly
2% overall are of Hispanic-American ethnicity. This means that
about 1 out of every 295 Black or African-American babies born
in Georgia from 2004 through 2008 had some form of SCD.
Types of SCD in babies born in Georgia, 2004-2008

•• Seven states were funded to participate in data collection:
California, Florida, Georgia, Michigan, New York, North
Carolina, and Pennsylvania.
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What is Sickle Cell Disease?
•• SCD is a group of inherited conditions that affect
hemoglobin, a protein that allows red blood cells
to carry oxygen to all parts of the body.
•• People with ancestry from parts of Africa, Asia and
the Mediterranean are among the most likely to be born
with these conditions.
•• Healthy red blood cells are round, and they move through
small blood vessels to carry oxygen to all
parts of the body. In SCD, the red blood cells
become hard and sticky and look like a C-shaped
farm tool called a “sickle.”
•• These cells can get stuck in the blood vessels and
block the normal flow of oxygen throughout the
body. This leads to a variety of health problems.

Through our surveillance efforts, we found 7,299 individuals
with confirmed or probable SCD in Georgia. Of these, 4,288 had
a diagnosis confirmed by a clinical center or through newborn
screening. The rest were identified because they had a sickle
cell diagnosis in one of the administrative datasets (hospital or
public insurance claims data) as well as health care utilization
consistent with SCD.1 These 7,299 individuals live in virtually
every county throughout the state of Georgia.
Number of individuals with SCD in Georgia counties
identified by surveillance*

•• The most common types of SCD are:
οο
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Hemoglobin SS Disease (HbSS): People who have this
form of SCD inherit two sickle cell hemoglobin genes
(“S”), one from each parent. This is commonly called
sickle cell anemia and is usually the most severe form of
the disease.
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Hemoglobin SC Disease (HbSC): People who have this
form of SCD inherit a sickle cell hemoglobin gene (“S”)
from one parent and from the other parent a gene for
abnormal hemoglobin called “C”. This is usually a milder
form of SCD.
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Hemoglobin S beta thalassemia (HbS beta thalassemia):
People who have this form of SCD inherit one sickle cell
hemoglobin gene (“S”) from one parent and one gene
for beta thalassemia, another type of anemia, from the
other parent. There are two types of beta thalassemia:
“0” and “+”. Those with HbS beta0-thalassemia usually
have a more severe form of SCD. People with HbS
beta+-thalassemia tend to have a milder form of SCD.
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*Unduplicated
individuals who
lived in GA at any
time from 2004
through 2008.

We identified individuals living with SCD from newborns to those
over 70 years of age; the figure below shows the age distribution
of identified cases. Because our surveillance methods relied heavily
on utilization data from newborn screening follow-up facilities and
public health insurance programs, we were more likely to identify
children living with the disease than their adult counterparts. The
decreased prevalence by age of people living with SCD illustrated
by the figure is in part due to our surveillance methods and not
only a reflection of early mortality from the disease.
Age distribution of individuals with SCD in Georgia
identified by RuSH
2,000

shows a pronounced increase after childhood. While
children age 0-19 averaged roughly four ER visits and
three hospitalizations over five years, those age 20
through 49 had more than fifteen ER visits in addition
to a greater frequency of hospital admissions. Although
not assessed by our surveillance, this may be in part
related to the natural history of the condition; factors
directly related to the transition from parental care to
independence, from pediatric to adult medical care,
and to changes in health insurance coverage. Transition
to independent self-care from parent directed
management may require some learning. In addition,
a break in the primary care medical home may cause
discontinuity in crucial primary prevention and clinical
support for patients with SCD.
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What you can do
•• Learn more about SCD:
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Again, because our surveillance methods relied on health care
utilization data and insurance claims, individuals with SCD who
did not seek care—some who were uninsured and some whose
disease was well managed—were less likely captured in our results.
The following health and health care utilization results, therefore,
likely represent those with greater health needs.
Of the 7,299 individuals with SCD identified, we have access to
utilization data for 94 percent (6,881) of them. Twenty-six percent
(1,798/6,881) had no hospitalizations, and 16 percent (1,131/6,881)
had no ER visits during the five-year period from 2004 to 2008. The
figure below illustrates the five-year average number of hospital
admissions and ER visits by age group. This health care utilization
Average number of hospital encounters per
individual with SCD, by age group, 2004-2008
In-patient stays/person
ER visits/person
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Sickle Cell Information Center website:
scinfo.org
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Comprehensive Sickle Cell Center at Georgia
Regents University: 706-721-2171
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Georgia Comprehensive Sickle Cell Center at
Grady Health System: 404-616-3572
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Aflac Cancer and Blood Disorders Center of
Children’s Healthcare of Atlanta: 404-785-1200
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Health and Health Care
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•• Report babies and children with SCD to the
Department of Public Health (sickle cell is a
notifiable disease for children through age 18 in
Georgia): health.state.ga.us/epi/disease/report;
404-657-2588
•• Refer SCD patients and families for information
and support services: Sickle Cell Foundation of
Georgia, Inc.: www.sicklecellga.org; 404-755-1641;
800-326-5287 (toll-free)
•• Educate patients on the role of newborn
screening: Georgia Department of Public Health
Newborn Screening Program health.state.ga.us/
programs/nsmscd; 404-657-4143
•• Submit samples for confirmatory testing
to Georgia’s reference laboratory for
hemoglobinopathies, the Titus HJ Huisman
Hemoglobinopathy Laboratory at Georgia
Regents University: georgiahealth.edu/centers/
sicklecell; 706-721-9640
•• Learn more about the RuSH Project: Angela
Snyder, angiesnyder@gsu.edu
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For more information on SCD, please visit www.cdc.gov/ncbddd/sicklecell

